If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJudges Scientific Regulatory News (JDG)

Share Price Information for Judges Scientific (JDG)

Share Price is delayed by 15 minutes
Get Live Data
4,675.00    -115.00 (-2.40%)
Bid:
4,600.00
Ask:
4,750.00
Spread: 150.00 (3.261%)
Market Cap: £311.39m
JDG Live PriceLast checked at - London Stock Exchange

Intraday Judges Scientific Share Chart

Result of AGM

20 May 2026 14:52

RNS Number : 1453F
Judges Scientific PLC
20 May 2026
 

20 May 2026

Judges Scientific plc

(the "Group" or "Judges")

Result of Annual General Meeting

Judges Scientific (AIM: JDG), a group focused on acquiring and developing companies in the scientific instrument sector, announces that, at the Annual General Meeting ("AGM") held today, all of the resolutions put to shareholders were duly passed.

The votes received at the AGM are detailed below:

Resolution

Votes for

%

Discretion

%

Votes against

%

Votes withheld

Resolution 1 (Ordinary)

To receive and, if approved, adopt the audited financial statements of the Company for the year ended 31 December 2025 and the reports of the Directors and auditor thereon.  

 

2,684,182

94.00

171,100

 

5.99

191

0.01

3, 233

Resolution 2 (Ordinary)

To approve the Directors' Remuneration Report, other than the part containing the Directors' Remuneration Policy, as set out in the Annual Report and Accounts 2025.

 

2,640,403

92.71

171,100

6.01

 

36,383

1.28

 

10,820

Resolution 3 (Ordinary)

To approve the Remuneration Policy as set out in the Annual Report and Accounts 2025, to take effect immediately after the conclusion of the meeting.

 

2,596,197

91.16

171,100

6.01

80,577

2.83

 

10,832

Resolution 4 (Ordinary)

To re-elect David Cicurel, who retires annually, as a Director.

 

2,340,679

84.46

171,100

 

6.17

 

259,590

9.37

87,337

Resolution 5 (Ordinary)

To re-elect Tim Prestidge, who retires annually, as a Director.

 

2,679,935

 

93.79

171,100

 

5.99

 

6,389

 

0.22

 

1,282

Resolution 6 (Ordinary)

To re-elect Ralph Elman, who retires annually, as a Director.

 

2,306,095

 

80.70

 

171,100

 

5.99

 

380,263

 

13.31

 

1,248

Resolution 7 (Ordinary)

To re-elect Brad Ormsby, who retires annually, as a Director.

 

2,655,154

 

93.89

171,100

 

6.05

 

1,820

 

0.06

 

30,632

Resolution 8 (Ordinary)

To re-elect Charles Holroyd, who retires annually, as a Director.

2,493,312

 

87.24

171,100

 

5.99

 

193,537

6.77

 

757

Resolution 9 (Ordinary)

To re-elect Lushani Kodituwakku, who retires annually, as a Director.

 

2,516,972

88.08

171,100

 

5.99

 

169,300

5.93

 

1,334

Resolution 10 (Ordinary)

To re-elect Susan Nyman, who retires annually, as a Director.

 

2,521,919

88.26

 

171,100

 

5.99

 

164,357

 

5.75

1,330

Resolution 11 (Ordinary)

To elect Ian Wilcock, who retires annually, as a Director.

 

2,655,318

92.92

171,100

 

5.99

31,006

 

1.09

1,282

Resolution 12 (Ordinary)

To approve a final dividend of 82.3p per Ordinary share.

 

2,686,222

93.97

171,100

5.99

1,250

0.04

134

Resolution 13 (Ordinary)

To approve the re-appointment of BDO UK LLP as auditor to hold office formally from the conclusion of this meeting until the conclusion of the next general meeting at which financial statements are laid before the Company and to authorise the Directors to fix the remuneration of the auditor for the year ending 31 December 2026.

 

2,056,655

 

71.95

 

171,100

 

5.99

630,644

 

22.06

 

307

Resolution 14 (Ordinary)

To authorise the directors to allot relevant securities.

 

2,653,399

92.84

 

171,100

 

5.99

 

33,379

 

1.17

 

828

Resolution 15 (Special)

To disapply pre-emption rights

 

2,667,104

 

93.40

 

171,100

 

5.99

 

17,320

 

0.61

 

3,182

Resolution 16 (Special)

To resolve that the company be and is unconditionally authorised to make market purchases

 

2,619,667

 

93.80

171,100

6.13

1,833

0.07

 

66,106

* Percentage of votes cast excludes withheld votes.

The Board notes that more than 20% of shareholders voted against resolution thirteen. The Board intends to consult with shareholders to understand their views.

Details of the votes cast on all resolutions will also be available on the Company's website: www.judges.uk.com.

- Ends -  

 

For further information please contact:

 

 

 

Judges Scientific plc

Tim Prestidge, CEO

Brad Ormsby, CFO

Tel: +44 (0) 20 3829 6970

 

 

Shore Capital (Nominated Adviser & Joint Broker)

Stephane Auton

Harry Davies-Ball

Tel: +44 (0) 20 7408 4090

 

Liberum (Joint Broker)

Edward Mansfield

William King

Tel : +44 (0) 20 3100 2222

 

 

Investec Bank plc (Joint Broker)

Virginia Bull

Carlton Nelson

Tel: +44 (0) 207 597 4000

Alma (Financial Public Relations)

Sam Modlin

Rebecca Sanders-Hewett

Joe Pederzolli

Sarah Peters

Tel: +44 (0) 20 3405 0205

judges@almastrategic.com

 

 

Notes to editors:

Judges Scientific plc (AIM: JDG), is a group focused on acquiring and developing companies in the scientific instrument sector. The Group consists of 25 businesses acquired since 2005.

The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, scientific research facilities, manufacturers and regulatory authorities. The UK is a recognised centre of excellence for scientific instruments. The Group has received five Queen's Awards for innovation and export.

The Group's companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins.

Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash. Shareholder returns are created through the reduction of debt, organic growth and dividends.

For further information, please visit www.judges.uk.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGSEUFDSEMSELI
Date   Source Headline
22nd Jun 20267:00 amRNSBlocklisting Return
19th Jun 20267:00 amRNSAppointment of auditor
11th Jun 20264:34 pmRNSDirector/PDMR Shareholding
1st Jun 20262:24 pmRNSTotal Voting Rights
26th May 20265:18 pmRNSPurchase of Ordinary Shares
20th May 20262:52 pmRNSResult of AGM
11th May 20263:10 pmRNSDirector/PDMR Shareholding
8th May 20265:05 pmRNSDirector/PDMR Shareholding
28th Apr 20267:00 amRNSNotice of AGM
22nd Apr 202611:53 amRNSConfirmation of Full Year Results
9th Apr 202611:14 amRNSDirector/PDMR Shareholding
2nd Apr 20267:00 amRNSDirector/PDMR Shareholding
31st Mar 20267:00 amRNSUnaudited Preliminary Results
25th Mar 20267:00 amRNSNotice of Investor Presentation
10th Mar 20267:00 amRNSDirector/PDMR Shareholding
9th Feb 20261:49 pmRNSDirector/PDMR Shareholding
2nd Feb 20269:38 amRNSTotal Voting Rights
29th Jan 20263:31 pmRNSDirector/PDMR Shareholding
29th Jan 20267:00 amRNSGrant of Options
22nd Jan 20267:00 amRNSFull Year Trading Statement and Notice of Results
8th Jan 202611:18 amRNSDirector/PDMR Shareholding
22nd Dec 20257:00 amRNSBlocklisting Return
22nd Dec 20257:00 amRNSBlocklisting Return
9th Dec 202510:25 amRNSDirector/PDMR Shareholding
3rd Dec 20257:00 amRNSAcquisition of the minority shareholding in GdB
26th Nov 20257:00 amRNSBoard Succession
13th Nov 20255:05 pmRNSDirector/PDMR Shareholding
11th Nov 202512:08 pmRNSDirector/PDMR Shareholding
3rd Nov 20257:00 amRNSTotal Voting Rights
20th Oct 20257:00 amRNSDirector/PDMR Shareholding
8th Oct 202511:43 amRNSDirector/PDMR Shareholding
1st Oct 202512:22 pmRNSTotal Voting Rights
18th Sep 20257:00 amRNSInterim Results
9th Sep 202511:42 amRNSDirector/PDMR Shareholding
21st Aug 20257:00 amRNSNotice of Investor Presentation
6th Aug 20255:46 pmRNSDirector/PDMR Shareholding
1st Aug 20257:00 amRNSTotal Voting Rights
30th Jul 20257:00 amRNSDirector/PDMR Shareholding
25th Jul 202510:07 amRNSDirector/PDMR Shareholding
24th Jul 20254:06 pmRNSDirector/PDMR Shareholding
24th Jul 20257:00 amRNSHalf Year Trading Update
8th Jul 20253:53 pmRNSDirector/PDMR Shareholding
1st Jul 20255:08 pmRNSTotal Voting Rights
1st Jul 20257:00 amRNSAppointment of Group Acquisitions Executive
23rd Jun 20257:00 amRNSBlocklisting Return
9th Jun 20251:37 pmRNSDirector/PDMR Shareholding
4th Jun 20255:03 pmRNSPurchase of Ordinary Shares
30th May 202512:06 pmRNSTotal Voting Rights
23rd May 202511:25 amRNSResult of AGM
13th May 20255:18 pmRNSPurchase of Ordinary Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.